Spinal Cord Infarcts: Risk Factors, Management, and Prognosis

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

There are no standard guidelines for treatment of spinal cord ischemia due to how rare it is and the diverse etiology and presentations involved. In addition, to date, there have been no large clinical trials examining ideal pharmacologic treatment options for spinal cord infarct. In our practice, we rely on hemodynamic augmentation initiated as soon as possible. Otherwise, treatment is usually geared towards the etiology of spinal cord ischemia. For instance, spinal cord ischemia occurring after aortic aneurysmal repair may improve with CSF drainage through a lumbar catheter in the periprocedural setting. Vertebral artery dissection should be treated with antithrombotics. If no clear etiology is found and there is evidence of atherosclerosis in other vascular beds, then management is focused on risk factor modification with blood pressure and glucose control, statins, and antithrombotics.

Original languageEnglish (US)
Article number28
JournalCurrent Treatment Options in Neurology
Volume19
Issue number8
DOIs
StatePublished - Aug 1 2017

Fingerprint

Spinal Cord Ischemia
Risk Management
Spinal Cord
Vertebral Artery Dissection
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Blood Vessels
Blood Glucose
Drainage
Atherosclerosis
Therapeutics
Catheters
Hemodynamics
Clinical Trials
Guidelines
Blood Pressure

Keywords

  • Spinal cord infarct
  • Vascular myelopathy

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Spinal Cord Infarcts : Risk Factors, Management, and Prognosis. / Nasr, Deena; Rabinstein, Alejandro.

In: Current Treatment Options in Neurology, Vol. 19, No. 8, 28, 01.08.2017.

Research output: Contribution to journalReview article

@article{a6dcd69a138a414ca08bade6bfb01e5b,
title = "Spinal Cord Infarcts: Risk Factors, Management, and Prognosis",
abstract = "There are no standard guidelines for treatment of spinal cord ischemia due to how rare it is and the diverse etiology and presentations involved. In addition, to date, there have been no large clinical trials examining ideal pharmacologic treatment options for spinal cord infarct. In our practice, we rely on hemodynamic augmentation initiated as soon as possible. Otherwise, treatment is usually geared towards the etiology of spinal cord ischemia. For instance, spinal cord ischemia occurring after aortic aneurysmal repair may improve with CSF drainage through a lumbar catheter in the periprocedural setting. Vertebral artery dissection should be treated with antithrombotics. If no clear etiology is found and there is evidence of atherosclerosis in other vascular beds, then management is focused on risk factor modification with blood pressure and glucose control, statins, and antithrombotics.",
keywords = "Spinal cord infarct, Vascular myelopathy",
author = "Deena Nasr and Alejandro Rabinstein",
year = "2017",
month = "8",
day = "1",
doi = "10.1007/s11940-017-0464-3",
language = "English (US)",
volume = "19",
journal = "Current Treatment Options in Neurology",
issn = "1092-8480",
publisher = "Current Science, Inc.",
number = "8",

}

TY - JOUR

T1 - Spinal Cord Infarcts

T2 - Risk Factors, Management, and Prognosis

AU - Nasr, Deena

AU - Rabinstein, Alejandro

PY - 2017/8/1

Y1 - 2017/8/1

N2 - There are no standard guidelines for treatment of spinal cord ischemia due to how rare it is and the diverse etiology and presentations involved. In addition, to date, there have been no large clinical trials examining ideal pharmacologic treatment options for spinal cord infarct. In our practice, we rely on hemodynamic augmentation initiated as soon as possible. Otherwise, treatment is usually geared towards the etiology of spinal cord ischemia. For instance, spinal cord ischemia occurring after aortic aneurysmal repair may improve with CSF drainage through a lumbar catheter in the periprocedural setting. Vertebral artery dissection should be treated with antithrombotics. If no clear etiology is found and there is evidence of atherosclerosis in other vascular beds, then management is focused on risk factor modification with blood pressure and glucose control, statins, and antithrombotics.

AB - There are no standard guidelines for treatment of spinal cord ischemia due to how rare it is and the diverse etiology and presentations involved. In addition, to date, there have been no large clinical trials examining ideal pharmacologic treatment options for spinal cord infarct. In our practice, we rely on hemodynamic augmentation initiated as soon as possible. Otherwise, treatment is usually geared towards the etiology of spinal cord ischemia. For instance, spinal cord ischemia occurring after aortic aneurysmal repair may improve with CSF drainage through a lumbar catheter in the periprocedural setting. Vertebral artery dissection should be treated with antithrombotics. If no clear etiology is found and there is evidence of atherosclerosis in other vascular beds, then management is focused on risk factor modification with blood pressure and glucose control, statins, and antithrombotics.

KW - Spinal cord infarct

KW - Vascular myelopathy

UR - http://www.scopus.com/inward/record.url?scp=85021906007&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021906007&partnerID=8YFLogxK

U2 - 10.1007/s11940-017-0464-3

DO - 10.1007/s11940-017-0464-3

M3 - Review article

AN - SCOPUS:85021906007

VL - 19

JO - Current Treatment Options in Neurology

JF - Current Treatment Options in Neurology

SN - 1092-8480

IS - 8

M1 - 28

ER -